Current Opinion in Hematology

(The H4-Index of Current Opinion in Hematology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
An update on the pathophysiology of immune thrombocytopenia84
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies47
Structural organization of the bone marrow and its role in hematopoiesis39
Brothers in arms: platelets and neutrophils in ischemic stroke32
Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease31
Mechanisms of immunothrombosis in COVID-1931
The rebirth of the contact pathway: a new therapeutic target31
Human babesiosis: recent advances and future challenges23
Advances in chimeric antigen receptor T cells23
The interaction between the complement system and hemostatic factors21
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases20
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes18
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms17
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia17
Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology16
Update on the pathophysiology of transfusion-related acute lung injury16